Stevens Capital Management LP bought a new position in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) in the 3rd quarter, according to its most recent disclosure with the SEC. The firm bought 144,259 shares of the software maker’s stock, valued at approximately $2,053,000. Stevens Capital Management LP owned 0.08% of Allscripts Healthcare Solutions at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Wesbanco Bank Inc. lifted its position in shares of Allscripts Healthcare Solutions by 131.4% in the 2nd quarter. Wesbanco Bank Inc. now owns 147,587 shares of the software maker’s stock worth $1,883,000 after purchasing an additional 83,807 shares during the period. Dimensional Fund Advisors LP lifted its position in Allscripts Healthcare Solutions by 26.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 9,171,285 shares of the software maker’s stock valued at $117,026,000 after acquiring an additional 1,943,496 shares during the period. Dalton Greiner Hartman Maher & Co. purchased a new position in Allscripts Healthcare Solutions during the 2nd quarter valued at about $1,276,000. OppenheimerFunds Inc. lifted its position in Allscripts Healthcare Solutions by 9.4% during the 1st quarter. OppenheimerFunds Inc. now owns 31,445 shares of the software maker’s stock valued at $399,000 after acquiring an additional 2,701 shares during the period. Finally, Victory Capital Management Inc. lifted its position in Allscripts Healthcare Solutions by 6.8% during the 2nd quarter. Victory Capital Management Inc. now owns 1,627,164 shares of the software maker’s stock valued at $20,763,000 after acquiring an additional 103,395 shares during the period.

In other news, EVP Brian Farley sold 5,000 shares of Allscripts Healthcare Solutions stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $13.52, for a total value of $67,600.00. Following the completion of the sale, the executive vice president now directly owns 196,607 shares in the company, valued at $2,658,126.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Paul Black sold 15,000 shares of Allscripts Healthcare Solutions stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $13.52, for a total transaction of $202,800.00. The disclosure for this sale can be found here. Insiders sold 35,000 shares of company stock valued at $473,800 over the last quarter. Company insiders own 0.75% of the company’s stock.

WARNING: “Stevens Capital Management LP Buys Shares of 144,259 Allscripts Healthcare Solutions, Inc. (MDRX)” was first reported by Daily Political and is the sole property of of Daily Political. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2017/11/12/stevens-capital-management-lp-buys-shares-of-144259-allscripts-healthcare-solutions-inc-mdrx.html.

Shares of Allscripts Healthcare Solutions, Inc. (NASDAQ MDRX) opened at $12.57 on Friday. Allscripts Healthcare Solutions, Inc. has a 12 month low of $9.96 and a 12 month high of $14.45. The company has a market cap of $2,271.16, a P/E ratio of 29.23, a PEG ratio of 2.24 and a beta of 1.35. The company has a quick ratio of 0.93, a current ratio of 0.98 and a debt-to-equity ratio of 1.20.

A number of research analysts recently issued reports on MDRX shares. Dougherty & Co reissued a “buy” rating and set a $16.00 price target (up from $15.00) on shares of Allscripts Healthcare Solutions in a research report on Tuesday, October 3rd. Cantor Fitzgerald reissued a “buy” rating and set a $17.00 price target on shares of Allscripts Healthcare Solutions in a research report on Wednesday, September 27th. Jefferies Group LLC set a $17.00 price target on shares of Allscripts Healthcare Solutions and gave the company a “buy” rating in a research report on Friday, August 25th. Maxim Group reissued a “buy” rating and set a $16.00 price target on shares of Allscripts Healthcare Solutions in a research report on Friday, August 4th. Finally, Robert W. Baird reissued a “buy” rating and set a $16.00 price target on shares of Allscripts Healthcare Solutions in a research report on Tuesday, October 17th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and eleven have given a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $15.06.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.